Collections / Prostate needle biopsies pre- and post-ADT: Count matrices, histological-, and Androgen receptor immunohistochemistry images

Prostate needle biopsies pre- and post-ADT: Count matrices, histological-, and Androgen receptor immunohistochemistry images

Datasets24
Size~22.5 GB
Assayspatial transcriptomics
Samplehuman · prostate gland
KindComparison
Flag a data issue
10.1038/s41467-022-33069-3 ↗
Python · sddb client
from sddb import Catalog

cohort = Catalog().collection("doi-10-1038-s41467-022-33069-3")
cohort.members        # the 24 datasets as a table

print(cohort.licenses())              # check the terms before you download

sdatas = cohort.to_dict()             # {uid: SpatialData}, cached locally
# or keep the .zarr files in a folder of your choice:
# sdatas = cohort.to_dict(dest="data/")
Python · lamindb

Needs pip install lamindb and network access to the Lamin database, which is limited during the alpha. If it fails, use the Client tab.

import lamindb as ln

db = ln.DB("scverse/spatialdata-db")
coll = db.Collection.get(key="doi-10.1038/s41467-022-33069-3")
coll.ordered_artifacts.to_dataframe()   # the 24 members, ordered

# download every member .zarr to the local cache:
paths = [a.cache() for a in coll.ordered_artifacts.all()]
Shell
# sddb client: download every member .zarr into data/
sddb-cli download --collection doi-10-1038-s41467-022-33069-3 --dest data/

Licenses: 24 CC BY-NC-SA 4.0

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

The molecular mechanisms underlying lethal castration-resistant prostate cancer remain poorly understood, with intratumoral heterogeneity a likely contributing factor. To examine the temporal aspects of resistance, we analyze tumor heterogeneity in needle biopsies collected before and after treatment with androgen deprivation therapy. By doing so, we are able to couple clinical responsiveness and morphological information such as Gleason score to transcriptome-wide data. Our data-driven analysis of transcriptomes identifies several distinct intratumoral cell populations, characterized by their unique gene expression profiles. Certain cell populations present before treatment exhibit gene expression profiles that match those of resistant tumor cell clusters, present after treatment. We confirm that these clusters are resistant by the localization of active androgen receptors to the nuclei in cancer cells post-treatment. Our data also demonstrates that most stromal cells adjacent to resistant clusters do not express the androgen receptor, and we identify differentially expressed genes for these cells. Altogether, this study shows the potential to increase the power in predicting resistant tumors.

Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND9
human prostate gland prostate cancer 1.1 GB 177 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.1 GB
Spots177
Magnification40x · 0.270 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND18
human prostate gland prostate cancer 955 MB 209 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size955 MB
Spots209
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND23
human prostate gland prostate cancer 729 MB 117 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size729 MB
Spots117
Magnification40x · 0.274 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND10
human prostate gland prostate cancer 1.2 GB 129 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.2 GB
Spots129
Magnification40x · 0.274 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND5
human prostate gland prostate cancer 1.1 GB 170 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.1 GB
Spots170
Magnification40x · 0.276 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND16
human prostate gland prostate cancer 1.1 GB 193 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.1 GB
Spots193
Magnification40x · 0.271 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND20
human prostate gland prostate cancer 755 MB 173 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size755 MB
Spots173
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND1
human prostate gland prostate cancer 608 MB 176 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size608 MB
Spots176
Magnification40x · 0.270 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND17
human prostate gland prostate cancer 940 MB 261 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size940 MB
Spots261
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND19
human prostate gland prostate cancer 785 MB 155 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size785 MB
Spots155
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND21
human prostate gland prostate cancer 800 MB 151 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size800 MB
Spots151
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND8
human prostate gland prostate cancer 1.4 GB 121 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.4 GB
Spots121
Magnification40x · 0.272 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND2
human prostate gland prostate cancer 531 MB 201 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size531 MB
Spots201
Magnification40x · 0.278 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND6
human prostate gland prostate cancer 1.0 GB 164 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.0 GB
Spots164
Magnification40x · 0.276 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND15
human prostate gland prostate cancer 1.0 GB 202 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.0 GB
Spots202
Magnification40x · 0.287 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND11
human prostate gland prostate cancer 988 MB 216 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size988 MB
Spots216
Magnification40x · 0.270 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND7
human prostate gland prostate cancer 527 MB 82 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size527 MB
Spots82
Magnification40x · 0.270 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND22
human prostate gland prostate cancer 912 MB 146 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size912 MB
Spots146
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND4
human prostate gland prostate cancer 1.3 GB 112 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.3 GB
Spots112
Magnification40x · 0.274 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND12
human prostate gland prostate cancer 1.1 GB 190 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.1 GB
Spots190
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND24
human prostate gland prostate cancer 687 MB 136 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size687 MB
Spots136
Magnification40x · 0.275 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND13
human prostate gland prostate cancer 1.0 GB 183 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.0 GB
Spots183
Magnification40x · 0.280 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND3
human prostate gland prostate cancer 845 MB 161 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size845 MB
Spots161
Magnification40x · 0.276 µm/px
bronze H&E Open in Vitessce
Open in Vitessce
spatial transcriptomics
Human prostate gland
MEND14
human prostate gland prostate cancer 1.2 GB 161 spots bronze H&E
Technologyspatial transcriptomics
Organismhuman
Tissueprostate gland
Conditionprostate cancer
Size1.2 GB
Spots161
Magnification40x · 0.279 µm/px
bronze H&E Open in Vitessce

Cite this collection

doi.org/10.1038/s41467-022-33069-3 ↗
BibTeX
@article{Marklund_2022,
  title = {Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones},
  volume = {13},
  ISSN = {2041-1723},
  url = {http://dx.doi.org/10.1038/s41467-022-33069-3},
  DOI = {10.1038/s41467-022-33069-3},
  number = {1},
  journal = {Nature Communications},
  publisher = {Springer Science and Business Media LLC},
  author = {Marklund, Maja and Schultz, Niklas and Friedrich, Stefanie and Berglund, Emelie and Tarish, Firas and Tanoglidi, Anna and Liu, Yao and Bergenstråhle, Ludvig and Erickson, Andrew and Helleday, Thomas and Lamb, Alastair D. and Sonnhammer, Erik and Lundeberg, Joakim},
  year = {2022},
  month = Sept
}